U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H34O5
Molecular Weight 390.5131
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIGOXIGENIN

SMILES

[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C5=CC(=O)OC5)[C@@]1(C)CC[C@H](O)C2

InChI

InChIKey=SHIBSTMRCDJXLN-KCZCNTNESA-N
InChI=1S/C23H34O5/c1-21-7-5-15(24)10-14(21)3-4-17-18(21)11-19(25)22(2)16(6-8-23(17,22)27)13-9-20(26)28-12-13/h9,14-19,24-25,27H,3-8,10-12H2,1-2H3/t14-,15+,16-,17-,18+,19-,21+,22+,23+/m1/s1

HIDE SMILES / InChI

Molecular Formula C23H34O5
Molecular Weight 390.5131
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 9
E/Z Centers 0
Optical Activity UNSPECIFIED

Digoxigenin is a 390.5 Da steroid expressed in heart, kidney, liver, adrenal gland, cerebral cortex, lung and placental tissues; Antibodies to Digoxigenin can be used to study tumor development. Bispecific antibodies (bsAbs) that bind to both tumor specific antigens on the cell surface and to haptens such as digoxigenin (Dig) can direct digoxigeninylated payloads to tumor cells. Digoxigenin is widely used as a method for generating non-radioactive probes, and is an alternative to biotinylation.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: CHEMBL614056
317.5 nM [IC50]
507.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
One-, two-, and three-color whole-mount in situ hybridization to Drosophila embryos.
2001 Apr
Nonradioactive in situ hybridization to xenopus tissue sections.
2001 Apr
A system to enhance the sensitivity of digoxigenin-labelled probe: detection of B19 DNA in serum samples.
2001 Apr
[Molecular diagnosis of fragile X syndrome with polymerase chain reaction: application of a diagnostic protocol in 50 families from northern Spain].
2001 Apr
Non-radioactive digoxigenin DNA labeling and immunologic detection of HSV PCR products.
2001 Dec
[Pathogenecity and replication of transfusion transmitted virus in liver tissue by in situ hybridization].
2001 Jan
Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction.
2001 Jun
Differentiation of porcine circovirus 1 and 2 in formalin-fixed, paraffin-wax-embedded tissues from pigs with postweaning multisystemic wasting syndrome by in-situ hybridisation.
2001 Jun
Nonradioactive detection of the common Connexin 26 167delT and 35delG mutations and frequencies among Ashkenazi Jews.
2001 Jun
Isolation of high-affinity ligand-binding proteins by periplasmic expression with cytometric screening (PECS).
2001 Jun
Cellular localization of BM88 mRNA in paraffin-embedded rat brain sections by combined immunohistochemistry and non-radioactive in situ hybridization.
2001 Jun
Developmental patterns of ceramide glucosyltransferase (GlcT-1) expression in the mouse: in situ hybridization using DIG-labeled RNA probes.
2001 Jun 30
[Development of donor cells in chicken-duck chimeric embryos].
2001 Nov
Quantification of Escherichia coli genomic DNA contamination in recombinant protein preparations by polymerase chain reaction and affinity-based collection.
2001 Sep 1
Identification and preliminary characterization of mouse Adam33.
2002
Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma.
2002 Apr 22
Identification to the species level of the plant pathogens Phytophthora and Pythium by using unique sequences of the ITS1 region of ribosomal DNA as capture probes for PCR ELISA.
2002 Feb 5
Connective tissue growth factor is directly related to liver fibrosis.
2002 Jan-Feb
Molecular genetic evaluation of fluorescence diagnosis in bladder cancer.
2002 Mar
Down-regulation of Lsm1 is involved in human prostate cancer progression.
2002 Mar 18
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
2002 Mar 18
Genetic aberrations detected by comparative genomic hybridisation in vulvar cancers.
2002 Mar 18
Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization.
2002 Mar 22
Effect of developmental lead exposure on the expression of specific NMDA receptor subunit mRNAs in the hippocampus of neonatal rats by digoxigenin-labeled in situ hybridization histochemistry.
2002 Mar-Apr
Cysteine-free mutant of aequorin as a photolabel in immunoassay development.
2002 Mar-Apr
Conjugates bearing multiple formyl-methionyl peptides display enhanced binding to but not activation of phagocytic cells.
2002 Mar-Apr
High-sensitivity hybridization assay for quantitation of residual E. coli DNA.
2002 May
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Cellular uptake and intracellular distribution of liposomal digoxigenin-labeled oligodeoxynucleotides (ODNs) at several concentrations (0.1, 0.2, an 1.0 uM) in CaSki cells were studied.
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:40:58 GMT 2023
Edited
by admin
on Fri Dec 15 19:40:58 GMT 2023
Record UNII
NQ1SX9LNAU
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DIGOXIGENIN
HSDB   MI  
Common Name English
DIGOXIGENIN [MI]
Common Name English
DIGOXIN IMPURITY C [EP IMPURITY]
Common Name English
3.BETA.,12.BETA.,14-TRIHYDROXY-5.BETA.-CARD-20(22)-ENOLIDE
Systematic Name English
DIGOXIGENIN [HSDB]
Common Name English
Code System Code Type Description
CAS
1672-46-4
Created by admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
PRIMARY
MESH
D004076
Created by admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
PRIMARY
EPA CompTox
DTXSID6051778
Created by admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
PRIMARY
HSDB
7108
Created by admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
PRIMARY
PUBCHEM
15478
Created by admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
PRIMARY
ECHA (EC/EINECS)
216-806-2
Created by admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
PRIMARY
DRUG BANK
DB03671
Created by admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
PRIMARY
WIKIPEDIA
DIGOXIGENIN
Created by admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
PRIMARY
CHEBI
145797
Created by admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
PRIMARY
MERCK INDEX
m4455
Created by admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
PRIMARY Merck Index
FDA UNII
NQ1SX9LNAU
Created by admin on Fri Dec 15 19:40:58 GMT 2023 , Edited by admin on Fri Dec 15 19:40:58 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP